, anatomical, and pathophysiologic features. Conceptually, however, it has often been pondered
whether patients with varicose veins (C2) can undergo
treatment to prevent progression to CVI later in life. In
the Bonn Vein Study,128 1978 participants were followed
up for a mean of 6.6 years. The prevalence of varicose
veins rose from 22.7% to 